Showing results (1671-1680 of 1,873) with videos related to

Sort By:
Pageof 188
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung CancerAndreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
Journal of Medicinal Chemistry|April 10, 2018
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234Krisztina M Papp-Wallace, Nhu Q Nguyen, Michael R Jacobs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2022
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J Choudhury, Antonio Marra, Jane S Y Sui, et al.
Journal of Medicinal Chemistry|June 26, 2023
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate SpectrumRachel A Powers, Cynthia M June, Micah C Fernando, et al.
Plos Genetics|June 2, 2012
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesisPhuoc T Tran, Emelyn H Shroff, Timothy F Burns, et al.
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant EnterobacteriaceaeCourtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2010
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, MichiganDror Marchaim, Teena Chopra, Jason M Pogue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2020
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 StudyCharles M Rudin, Mark M Awad, Alejandro Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in CancerSabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancersSalomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
Pageof 188